Belgium’s IRE And SCK-CEN To Cooperate In Fight Against Prostate Cancer | |||
Sources | The Independent Nuclear News Agency | ||
---|---|---|---|
Sources URL | https://www.nucnet.org/news/belgium-s-ire-and-sck-cen-to-cooperate-in-fight-against-prostate-cancer-2-4-2020 | ||
Date of Registration | 2020-03-16 | Views | 1 |
- Details
-
Belgium’s National Institute for Radioelements (IRE) and nuclear research centre SCK-CEN have signed an agreement to join efforts on the production of lutetium-177 (Lu-177), a medical radioisotope mainly used to treat prostate cancer. In a joint statement the two organisations said the use of Lu-177 is one of the most promising approaches to treating prostate cancer. Currently, the medical radioisotope is used in hospitals to treat neuroendocrine cancers, the statement said.